Santo Domingo – The World Health Organization (WHO) has officially stated that there is no scientific evidence connecting the use of paracetamol during pregnancy to autism in children. This declaration comes in response to recent assertions made by former U.S. President Donald Trump, who advocated for limiting the use of Tylenol (a brand of paracetamol) among pregnant women and newborns. The WHO’s stance aims to dispel misinformation and reassure the public about the safety of this widely used medication. Dr. Rafael Montero, a public health specialist, strongly criticized Trump’s comments during an interview on Esto No Tiene Nombre, labeling them as baseless and unsupported by scientific research. Montero explained that paracetamol, whose active ingredient is acetaminophen, has been safely utilized for decades with no evidence linking it to autism spectrum disorder. He attributed the increase in autism diagnoses to enhanced detection methods and greater public awareness rather than medication use. Montero also pointed out that Trump had misinterpreted a Johns Hopkins meta-analysis, presenting it as conclusive evidence when it was not. Additionally, he questioned Trump’s focus on the Tylenol brand instead of the active compound, deeming it inappropriate. Montero emphasized the importance of patients consulting their healthcare providers for medical advice, a position echoed by the Dominican Society of Gynecologists, which reaffirmed the safety of acetaminophen when prescribed.